Atalanta Therapeutics

1 Follower


Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.


Add photos to showcase Atalanta Therapeutics’s culture


Add Atalanta Therapeutics’s values

Insider experiences

Share your experience of working at Atalanta Therapeutics

Alicia Secor
President & CEO
Aimee L. Jackson
Chief Scientific Officer
Morgan Molloy
Chief Corporate Development Officer
Michele Keough
SVP, Program & Alliance Management
Stephen Burke
SVP, Human Resources
Maurice Smith
Senior Director & Controller
Kimberly Dougherty
Senior Director, Facilities & Operations
Mark Murphy
Senior Facilities Manager
Bart G. Newland
General Counsel
Mary Alvarado
Administrative Assistant

Add your teams to show how people work together at Atalanta Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure